ImmunitoAI Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 23

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $6.13M

  • Investors
  • 18

ImmunitoAI General Information

Description

Developer of an AI-powered platform for antibody discovery intended to accelerate the development of novel antibody therapeutics. The company's platform offers novel antibody and antibody fragments against any epitope and does not depend upon a biological source, animal or human, for the lead molecule, and antibody therapeutics with pre-defined drug properties, enabling healthcare institutions to save time and money and increase efficiency.

Contact Information

Website
www.immunitoai.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2nd Floor, 879, NTI Layout, 2nd Phase, Rajeev Gandhi Nagar
  • Kodigehalli, Railway Parallel Road
  • Bengaluru, Karnataka 560097
  • India
+91 097426
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences
Corporate Office
  • 2nd Floor, 879, NTI Layout, 2nd Phase, Rajeev Gandhi Nagar
  • Kodigehalli, Railway Parallel Road
  • Bengaluru, Karnataka 560097
  • India
+91 097426

ImmunitoAI Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ImmunitoAI Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series A) 25-Nov-2025 $6.13M Completed Startup
8. Accelerator/Incubator Completed Startup
7. Secondary Transaction - Private Completed Startup
6. Accelerator/Incubator Completed Startup
5. Accelerator/Incubator 08-Dec-2023 Completed Startup
4. Accelerator/Incubator 18-Sep-2023 Completed Startup
3. Seed Round 08-Sep-2021 Completed Startup
2. Accelerator/Incubator 01-Jun-2021 $41K $98.1K Completed Startup
1. Accelerator/Incubator 18-Mar-2021 $57.2K $57.2K Completed Startup
To view ImmunitoAI’s complete valuation and funding history, request access »

ImmunitoAI Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
SERIES SEED A1 CCPS
SERIES SEED CCPS
PRE SERIES SEED CCPS 1,000 $0.135346 $56.34 $56.34 1x $56.34 5.43%
To view ImmunitoAI’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

ImmunitoAI Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ImmunitoAI Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
3one4 Capital Venture Capital Minority
AC Ventures (India) Venture Capital Minority
Anicut Capital Venture Capital Minority
Angel (individual) Minority
JITO Incubation & Innovation Foundation Accelerator/Incubator Minority
You’re viewing 5 of 18 investors. Get the full list »

Ready to get started?

Request a free trial

ImmunitoAI FAQs

  • When was ImmunitoAI founded?

    ImmunitoAI was founded in 2020.

  • Where is ImmunitoAI headquartered?

    ImmunitoAI is headquartered in Bengaluru, India.

  • What is the size of ImmunitoAI?

    ImmunitoAI has 23 total employees.

  • What industry is ImmunitoAI in?

    ImmunitoAI’s primary industry is Drug Discovery.

  • Is ImmunitoAI a private or public company?

    ImmunitoAI is a Private company.

  • What is the current valuation of ImmunitoAI?

    The current valuation of ImmunitoAI is .

  • What is ImmunitoAI’s current revenue?

    The current revenue for ImmunitoAI is .

  • How much funding has ImmunitoAI raised over time?

    ImmunitoAI has raised $9.1M.

  • Who are ImmunitoAI’s investors?

    3one4 Capital, AC Ventures (India), Anicut Capital, , and JITO Incubation & Innovation Foundation are 5 of 18 investors who have invested in ImmunitoAI.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process